Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies

Coughlin, Steven S.; Caplan, Lee S.; Stone, Rebecca

doi:10.1007/s11764-020-00855-1

Cited by 56 publications

(39 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because wearable devices offer data and feedback directly to patients, these tools are also used to promote physical activity among cancer patients and survivors 32 . Two recent reviews of studies using wearable devices to promote activity among cancer survivors found that interventions using wearable activity monitors had a positive impact on physical activity as well as symptoms and quality of life 33 , 34 . Moreover, real-time wearable device data may allow for tailored or just-in-time physical activity interventions 35 that may be further enhanced by the support of a coach who can review a patient’s real-time data and provide individualized support for behavior change 36 .…”

Section: Consumer Wearable Devices In Oncology Researchmentioning

confidence: 99%

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Low

2020

npj Digit. Med.

View full text Add to dashboard Cite

As smartphones and consumer wearable devices become more ubiquitous, there is a growing opportunity to capture rich mobile sensor data continuously, passively, and in real-world settings with minimal burden. In the context of cancer, changes in these passively sensed digital biomarkers may reflect meaningful variation in functional status, symptom burden, quality of life, and risk for adverse clinical outcomes. These data could enable real-time remote monitoring of patients between clinical encounters and more proactive, comprehensive, and personalized care. Over the past few years, small studies across a variety of cancer populations support the feasibility and potential clinical value of mobile sensors in oncology. Barriers to implementing mobile sensing in clinical oncology care include the challenges of managing and making sense of continuous sensor data, patient engagement issues, difficulty integrating sensor data into existing electronic health systems and clinical workflows, and ethical and privacy concerns. Multidisciplinary collaboration is needed to develop mobile sensing frameworks that overcome these barriers and that can be implemented at large-scale for remote monitoring of deteriorating health during or after cancer treatment or for promotion and tailoring of lifestyle or symptom management interventions. Leveraging digital technology has the potential to enrich scientific understanding of how cancer and its treatment affect patient lives, to use this understanding to offer more timely and personalized support to patients, and to improve clinical oncology outcomes.

show abstract

Section: Consumer Wearable Devices In Oncology Researchmentioning

confidence: 99%

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Low

2020

npj Digit. Med.

View full text Add to dashboard Cite

show abstract

“…Earlier studies have demonstrated the utility of wearable PA trackers in other chronic conditions. [18][19][20][21] For example, patients who underwent cardiac surgery using a tracking device significantly increased activity by about 500 steps just 2 days after surgery. 20 However, prior studies using trackers in HD patients are limited.…”

Section: Introductionmentioning

confidence: 99%

Physical activity in hemodialysis patients on nondialysis and dialysis days: Prospective observational study

Malhotra

Kumar

Virgen

et al. 2021

Hemodialysis International

View full text Add to dashboard Cite

Introduction: The physical decline in patients with end-stage kidney disease (ESKD) is associated with morbidity and mortality. Prior studies have attempted to promote physical activity at the time of dialysis; however, physical activity patterns on the nondialysis days are unknown. This study aimed to quantify physical activity on dialysis and nondialysis days in hemodialysis patients using a wearable actigraph. Methods: In this prospective study, subjects receiving hemodialysis were recruited from two outpatient dialysis units in urban San Diego and rural Imperial County, CA, between March 2018 and April 2019. Key inclusion criteria included: (1) receiving thrice weekly hemodialysis for ≥3 months, (2) age ≥ 18 years, and (3) able to walk with or without assistive devices. All participants wore a Fitbit Charge 2 tracker for a minimum of 4 weeks. The primary outcome was the number of steps per day. Each participant completed the Physical Activity Questionnaire, the Patient Health Questionnaire (PHQ)-9, the PROMIS Short form Fatigue Questionnaire at baseline, and the Participant Technology Experience Questionnaire at day 7 after study enrolment. Findings: Of the 52 recruited, 45 participants (urban = 25; rural = 20) completed the study. The mean age was 61 AE 15 years, 42% were women, 64% were Hispanic, and the mean dialysis vintage was 4.4 AE 3.0 years. For those with valid Fitbit data (defined as ≥10 hours of wear per day) for 28 days (n = 45), participants walked an average of 3688 steps per day, and 73% of participants were sedentary (<5000 steps/day). Participants aged >80 years were less active than younger (age < 65 years) participants (1232 vs. 4529 steps, P = 0.01). There were no statistical differences

show abstract

“…This may aid in identifying at-risk patients and provides another tool to consider in prognosis, especially if done remotely. In addition to tracking physical activity, wearables have been shown to increase physical activity among cancer patients and survivors as well [ 17 , 31 , 32 ]. Conversely, Rahimy et al found that a Fitbit program for survivors of endometrial cancer led to a transient 22% increase in average steps at 6 months, but by the end of the study at 9 months, participants had returned to their baseline activity levels with no change in BMI.…”

Section: Impact On Oncology Carementioning

confidence: 99%

Consumer Wearables and the Integration of New Objective Measures in Oncology: Patient and Provider Perspectives

Fonseka¹,

Woo²

2021

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

With one in five adults in the United States owning a smartwatch or fitness tracker, these devices are poised to impact all aspects of medicine by offering a more objective approach to replace self-reported data. Oncology has proved to be a prototypical example, and wearables offer immediate benefits to patients and oncologists with the ability to track symptoms and health metrics in real time. We aimed to review the recent literature on consumer-grade wearables and its current applications in cancer from the perspective of both the patient and the provider. The relevant studies suggested that these devices offer benefits, such as improved medication adherence and accuracy of symptom tracking over self-reported data, as well as insights that increase patient empowerment. Physical activity is consistently correlated with stronger patient outcomes, and a patient’s real-time metrics were found to be capable of tracking medication side effects and toxicity. Studies have made associations between wearable data and telomere shortening, cardiovascular disease, alcohol consumption, sleep apnea, and other conditions. The objective data obtained by the wearable presents a more complete picture of an individual’s health than the snapshot of a 15-minute office visit and a single set of vital signs. Real-time metrics can be translated into a digital phenotype that identifies risk factors specific to each patient, and shared risk factors across one’s social network may uncover common environmental exposures detrimental to one’s health. Wearable data and its upcoming integration with social media will be the foundation for the next generation of personalized medicine.

show abstract

Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies

Cited by 56 publications

References 28 publications

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Harnessing consumer smartphone and wearable sensors for clinical cancer research

Physical activity in hemodialysis patients on nondialysis and dialysis days: Prospective observational study

Consumer Wearables and the Integration of New Objective Measures in Oncology: Patient and Provider Perspectives

Contact Info

Product

Resources

About